Vol. 13 No. 3 (2020)

• In Memory of Prof. B.V. Afanasyev

  238-244

  • PDF_2020-13-3-238-244 (Russian)

INTERVIEWS

• New Treatment Options for Diffuse Large B-Cell Lymphoma

  Matthew J. Matasar

  245-259

  • PDF_2020-13-3-245-259 (Russian)

BONE MARROW TRANSPLANTATION

• Achievements and Challenges of Evidence-Based Medicine in Hematopoietic Stem Cell Transplantation: An Analysis of Single-Center and Multicenter Trials

  B.V. Afanasyev, Ivan Sergeevich Moiseev, N.G. Volkov, K.V. Lepik, N.B. Mikhailova, S.N. Bondarenko, L.S. Zubarovskaya, E.V. Morozova, O.V. Paina, P.V. Kozhokar, Zh.Z. Rakhmanova, O.V. Pirogova, K.S. Afanas’eva, A.V. Beinarovich, E.V. Semenova, O.G. Smykova, I.V. Markova, T.A. Bykova, A.L. Alyanskii, B.I. Smirnov, M.D. Vladovskaya, A.G. Smirnova, N.E. Ivanova, A.D. Kulagin

  260-272

  • PDF_2020-13-3-260-272 (Russian)

• Natural Killer Cells: License to Kill

  K.N. Melkova, Zhanna Vardanovna Sharoyan, G.P. Frolov

  273-279

  • PDF_2020-13-3-273-279 (Russian)

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  • PDF_2020-13-3-280-288 (Russian)

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Treatment with and without the Use of Granulocyte Colony-Stimulating Factor in Post-Transplantation Period

  S.V. Gritsaev, Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, V.N. Chebotkevich, S.S. Bessmeltsev, A.V. Chechetkin

  289-294

  • PDF_2020-13-3-289-294 (Russian)

EXPERIMENTAL STUDIES

• Efficient Transduction of T-Lymphocytes by Lentiviral Particles in Oncoimmunological Studies

  Ekaterina Konstantinovna Zaikova, K.A. Levchuk, D.Yu. Pozdnyakov, A.A. Daks, A.Yu. Zaritskey, A.V. Petukhov

  295-306

  • PDF_2020-13-3-295-306 (Russian)

LYMPHOID TUMORS

• The Use of Checkpoint Inhibitors in Classical Hodgkin’s Lymphoma during the COVID-19 Pandemic (Pirogov Medical Center’s Experience)

  Vladislav Olegovich Sarzhevskii, E.A. Demina, N.E. Mochkin, A.A. Spornik, A.A. Mamedova, E.G. Smirnova, A.E. Bannikova, A.A. Samoilova, V.S. Bogatyrev, O.Yu. Bronov, Yu.A. Abovich, V.Ya. Melnichenko

  307-315

  • PDF_2020-13-3-307-315 (Russian)

• Treatment of Aggressive Non-Hodgkin’s Lymphomas in Pregnancy

  Yana Konstantinovna Mangasarova, A.U. Magomedova, E.S. Nesterova, L.G. Gorenkova, F.E. Babaeva, R.G. Shmakov, S.K. Kravchenko

  316-321

  • PDF_2020-13-3-316-321 (Russian)

• Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice

  Nataliya Valer’evna Skvortsova, I.B. Kovynev, K.V. Khalzov, T.I. Pospelova, I.N. Nechunaeva

  322-334

  • PDF_2020-13-3-322-334 (Russian)

MYELOID TUMORS

• Early Response and Long-Term Outcomes of Ruxolitinib Therapy in Myelofibrosis: Multicenter Retrospective Study in 10 Centers of the Russian Federation

  E.G. Lomaia, Nadiya Tamazovna Siordiya, O.M. Senderova, O.E. Ochirova, E.B. Zhalsanova, A.Yu. Furtovskaya, G.P. Dimov, M. G. Pozina, O.Yu. Li, K.B. Trizna, M.A. Mikhalev, E.V. Sokurova, A.A. Otmorskaya, A.S. Khazieva, V.V. Ust’yantseva, Yu.D. Rogovaya, A.Yu. Zaritskey

  335-345

  • PDF_2020-13-3-335-345 (Russian)

• Pharmacokinetics, Safety, and Tolerance of Anagrelide, the First Domestic Generic, Compared with Reference Drug

  S.K. Zyryanov, V.V. Chistyakov, Olga Igorevna Butranova, E.S. Stepanova, O.G. Potanina, R.A. Abramovich

  346-353

  • PDF_2020-13-3-346-353 (Russian)

NEWS

• Breakthrough Hemolysis as a Challenging Issue in Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria (Resolution of Expert Panel)

  354-356

  • PDF_2020-13-3-354-356 (Russian)